Camber Pharmaceuticals Announces Addition of Olmesartan Medoxomil Tablets, USP

Camber Pharmaceuticals is excited to announce the addition of Olmesartan Medoxomil Tablets, USP, to its current portfolio.

Olmesartan Medoxomil Tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older to lower blood pressure.

Olmesartan Medoxomil Tablets, USP, are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.

To find out more information on Olmesartan Medoxomil Tablets, USP, please visit: www.camberpharma.com/olmesartan